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Background: In the context of a methicillin-susceptible Staphylococcus aureus (MSSA) outbreak, we aimed to
improve our knowledge of S. aureus (SA) epidemiology in the neonatal care center (NCC) of a tertiary care
teaching hospital.
Methods: We performed a complete one-year review of SA carrier, colonized or infected patients. Monthly prevalence
and incidence of SA intestinal carriage, colonization and infection were calculated and the types of infection analysed.
During the MSSA outbreak, strains were studied for antimicrobial resistance, content of virulence genes and
comparative fingerprint in Pulsed-Field Gel Electrophoresis. Hand hygiene and catheter-related practices were
assessed by direct observational audits. Environmental investigation was performed in search of a SA reservoir.
Results: Epidemiological analyses showed 2 or 3 prevalence peaks on a background of SA endemicity. In the
NCC, during 2009, overall MSSA prevalence did not decrease below 5.5%, while mean MRSA prevalence was about
1.53%. Analysis of infection cases revealed that the outbreak corresponded to the emergence of catheter-related
infections and was probably related to the relaxation in infection control practices in a context of high colonization
pressure. Health care workers’ white coats appeared as a potential environmental reservoir that could perpetuate SA
circulation in the ward.
Conclusion: This report emphasizes the importance of integrating MSSA along with methicillin-resistant SA in a
program of epidemiological surveillance in the NCC.
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Methicillin-susceptible Staphylococcus aureusBackground
The high incidence of hospital-acquired infections (HAIs)
in neonatal intensive care units (NICUs) is related to the
immaturity of patients who are also subjected to many
invasive procedures. Coagulase negative staphylococci
(CoNS) and Staphylococcus aureus (SA) are the main
and often sole bacteria colonizing the digestive tract of* Correspondence: sara.romano-bertrand@univ-montp1.fr
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article, unless otherwise stated.low birth-weight infants during the 3 first weeks of life
[1]. Furthermore, CoNS and SA are responsible for
most infections in hospitalized preterm infants [2-4].
As in other hospital units, methicillin-resistant S. aureus
(MRSA) outbreaks have often been reported in NICUs
[5-8] whereas, at first glance, methicillin-susceptible S.
aureus (MSSA) outbreaks seem less frequent. Indeed, a
PubMed database search returns 1108 papers for “MRSA
outbreak” versus 52 for “MSSA outbreak” (January 2014).
In second analysis, the scarcity of MSSA outbreaks could
be due to a bias in detection or reporting, MRSA being
one of the most threatening pathogens as well as the prin-
cipal indicator of nosocomial risk. Patients’ screening and
outbreak alert systems in most hospitals focus on MRSA,ed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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with little or no insight into molecular typing and epi-
demiology. However, a study of 358 S. aureus strains
(2,007,681 days of hospitalization in 32 healthcare institu-
tions) showed there is a significant increase of bloodstream
HAIs largely due to MSSA strains [9,10].
The published MSSA outbreaks concerned merely
NICUs [11-13], burns units [14] and multi-resistant
MSSA [14,15]. The spread of MSSA clonal strains in
NICUs seems to be very successful. For instance, in a
5-year outbreak affecting 202 neonates, classical control
measures failed to end the outbreak [13] but atypical res-
ervoirs near the patient, such as skin protectant [13] and
ultrasound gel [12] were found. Intestinal carriage of SA
seems to be neglected in NICUs, although it frequently
occurs in infants [1,16,17]. Furthermore, it is associated
with a high risk of skin colonization which can in turn in-
crease the risk of infections, environmental contamination
and cross transmission [17].
The aim of this study is to describe the epidemiology
of SA in the neonatal care center (NCC) of the Montpellier
Academic Hospital. An increase of MSSA colonization and
infection cases in the NCC led to a complete investigation:
(i) analysis of cases, (ii) assessment of hygiene practices
(hand hygiene and catheter-related care) (iii) search of SA
environmental reservoir, (iv) molecular typing. The out-
break was confirmed and related to the spread of a com-
mon strain with a probable environmental reservoir.
Methods
Settings, patients and infection surveillance policies
The NCC of Montpellier is organized in 3 sectors: the
paediatric reanimation and intensive care unit or PRICU
(14 beds in 9 boxes for neonates including very preterm
neonates and 6 beds in 5 rooms for infants), the NICU
(24 beds in 10 boxes), and a mother-cum-child or
“kangaroo” ward (9 beds in individual rooms, and 3 beds
in a nursery).
Hospitalized patients in the PRICU are low birth-weight
(<1500 g) preterm infants and newborns aged < 1 month
with diseases or unstable states. The PRICU also hosts
newborns having surgery and older children requiring
intensive care. Newborns are transferred to the NICU
once their clinical state is stabilised or improved. As soon
as their condition allows, patients are transferred to the
kangaroo ward before returning home.
The medical and paramedical teams from the PRICU,
the NICU and the kangaroo ward, a microbiologist and
a member of the infection control (IC) team meet weekly
to discuss HAI cases, differentiating true HAIs from
bacterial carriage or colonization by confronting micro-
biological data, biological and clinical contexts and ini-
tiation of antimicrobial treatment [18]. Infants are
considered as colonized if a positive culture is obtainedfrom a non-sterile site, and infected if a pathogen is
isolated from a normally sterile site or if cultures are
obtained for clinical purposes. In addition, in the NICU
sector, the digestive carriage of SA and multi-drug resist-
ant bacteria (MDRB) is screened for each patient upon
admission and once a week thereafter. A positive culture
from a digestive sample is considered as SA carriage
[17]. Stool samples are cultured to determine methicil-
lin and ceftazidime resistance in staphylococci and
gram-negative bacilli, respectively. MDRB detection
leads to supplementary infection control measures to
prevent cross-contamination among patients, and to
further environmental investigations. A real-time sur-
veillance is implemented by a daily account of all newly
MDRB colonized or infected patients by the microbiologist,
using an antibiotic resistance information system (Sirweb®,
i2a, Montpellier, France). Surveillance data is transmitted to
the IC team via the hospital information system. This
automatic surveillance system operates for MDRB only;
hence outbreaks involving susceptible micro-organisms
can be detected only through clinical observation of an in-
creased number of cases over a given time span.
Outbreak investigation of MSSA infections
This clinical surveillance thus detected an increase in
HAIs involving MSSA, leading to an outbreak investiga-
tion by the IC team including analysis of patients’ medical
records, environmental investigation, and assessment of
healthcare practices. Clinical strains were tested for their
antimicrobial susceptibility by disk diffusion assay ac-
cording to the French Committee for Antimicrobial
Susceptibility Testing (Members of the Société Française
de Microbiologie Committee, 2003). After extraction of
the DNA performed according to Predari et al. [19],
isolates were screened for genes encoding staphylococcal
enterotoxins A (sea), toxic shock syndrome toxin 1 (tst),
Panton-Valentine leukocidin (PVL; luk- PV) [2-4]. Clinical
MSSA strains were explored by genomotyping to deter-
mine genetic links between them. For this purpose, intact
genomic DNA was extracted in agarose plugs and digested
by the endonuclease SmaI, as described [20]. Macrorestric-
tion fragments were separated by pulsed-field gel elec-
tophoresis (PFGE) by a ramp of pulses of 20s to 5 s at
6 V/min during 24 h on CHEF-DRII apparatus (Biorad).
Dry and humid surfaces were sampled, as well as
health-care workers’ clothes (i.e.: white over-gowns used
for the manipulation of central venous lines, especially
the front part which comes into contact with patients);
the cotton swabs used for sampling served to inoculate
trypticase-soy, Chapman and McConkey agar plates
(bioMérieux, France) which were incubated at 37°C for
48 h. Water was sampled at different points of use in
the units in 250 mL sterile bottles containing sodium
thiosulfate for chloride inhibition. Water samples were
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then incubated at 30°C during 48 h on Chapman agar.
Healthcare practices in the NCC were audited by direct
observation of hand hygiene opportunities (a minimum of
30 observations) and central venous catheter manipula-
tions (a minimum of 5 observations).
Epidemiology
Monthly prevalence and incidence of SA colonizations
and infections were calculated for each sector, as well as
the prevalence of MSSA and MRSA for all the NCC.
Prevalence was defined as number of patients with SA
per total number of hospitalized patients in the month,
reflecting the endemicity of SA in the NCC. The incidence
was the ratio of new cases on new admissions during the
month. Duplicate cases in a same sector (repeat admission)
or between sectors (transfer of a previously known case)
were excluded from prevalence and incidence calculations.
Ethical considerations
We studied bacterial isolates obtained during the daily
care of preterm infants in our NICU. Therefore, this ob-
servational study was fully in line with the routine care of
preterm infants and did not require the agreement of the
ethical committee of our institution.
Results
SA epidemiology in the NCC
One hundred and thirty nine patients admitted to the
NCC were included in the epidemiological study. Distri-
bution of carriage, colonization and infection cases for
each sector is summarized in Figure 1. Fifty-four patients
were carriers, colonized or infected by SA, 22 in the sum-
mer period (4, 6, 4 and 8 respectively in June, July, August
and September). In the NICU and kangaroo ward, mostFigure 1 Distribution of SA carriage, colonisation and infection for eaSA isolates were involved in carriage with a low frequency
of colonization and/or infection. By contrast, patients in
the PRICU with more instable clinical status were more
frequently colonized and/or infected.
Distribution of the different types of SA positive clinical
samples corresponding to colonization and/or infection by
care sector is summarized in Table 1. Most of them oc-
curred in the PRICU (70.9% of all positive samples),
followed by the NICU (23.3%) and the kangaroo ward
(5.8%). Respiratory samples were predominant in the
NCC, overall representing 52.3% of all clinical samples,
especially in the PRICU (63.9%). Ophthalmic samples
were the second most frequent with about 17.5%,
followed by blood cultures (10%) and catheter samples
(7%). By care sector, ophthalmic colonization and infec-
tions predominated in the NICU, and came equal with
respiratory samples (40% each) in the kangaroo ward.
SA positive catheter samples and blood cultures were
mainly present in the PRICU (8 of the 10 samples), 2
other cases were found in the NICU, and none in the
kangaroo ward where patients are less often perfused.
The evolution of SA monthly prevalence for each sector
is represented on Figure 2. In the NICU, where digestive
carriage of SA is routinely screened, average prevalence
reached 12.9%, with increasing rates in March (20%),
August (17%) and November (22%). In other sectors,
because of the absence of systematic screening, preva-
lence rates obtained were certainly underestimated and
did not reflect the real presence of SA. In the PRICU,
average rates were around 5.5% and ranged generally
between 5 and 10%, except in November and December
when they fell to 3.1% and 1.1% respectively. In the
kangaroo ward, rates were more variable, roughly around
6.2% with 2 peaks in June (16.2%) and November (14.3%).
Monthly incidences of SA clinical samples and infectionsch sector in 2009. All = carriage, colonization and infection.
Table 1 Typological analysis of colonization- and
infection-associated clinical SA positive samples by care
sector
NICU PRICU Kangaroo ward Total
n % n % n % n %
Sites of isolation
Respiratory 4 20 39 63.9 2 40 45 52.3
Ophthalmic 9 45 4 6.6 2 40 15 17.5
Blood 2 10 8 13.1 0 0 10 11.6
Catheter 2 10 5 8.2 0 0 7 8.1
Other 3 15 5 8.2 1 20 9 10.5
Total 20 61 5 86
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dences over the year was very similar to prevalence
curves, especially in the NICU with increased incidence
in March (26.1%), July (20%) and August (17.4%), and
November (28.9%) (data not shown). Finally, epidemio-
logical analyses showed several epidemic episodes on a
background of SA endemicity: each care sector presented
2 or 3 prevalence peaks.
Monthly MSSA and MRSA prevalence rates in the en-
tire NCC are summarized in Figure 3. The overall
MSSA prevalence did not decrease below 5.5% (in May
and October), and reached 13.2% in March. Concerning
MRSA, the mean prevalence in 2009 for all of the NCC
was around 1.53%, with increasing rates in September
(3.7%) and November (6%). These results show that
MSSA endemicity largely exceeded MRSA endemicity
in the NCC. Incidence rates confirmed that new cases
of MSSA were also more frequent than MRSA in the
NCC (data not shown).
Monthly analysis of infections showed an emergence of
SA bacteraemia and catheter-linked infections in summer.Figure 2 Monthly prevalence of SA carriage, colonization and infectioFor one of them, positive blood-culture was associated
with a positive catheter. The origin of the other bacter-
aemia was not found.
MSSA infections outbreak
The epidemic curve of SA infection cases between January
and December 2009 is shown in Figure 4. Among the 17
SA infections, 15 were caused by MSSA strains versus 2
by MRSA. Outbreak alert was sounded because of an in-
crease in MSSA case numbers observed in July (4 cases)
and August (2 cases), contrasting with the average rate
of one case every 2 months until then. Six other SA
infections occurred in September and October with
respectively 3 cases including one MRSA infection each
month. Another MSSA infection in November and one in
December were also reported.
The 6 cases of July and August led to the outbreak in-
vestigation. All 6 patients were hospitalized in the PRICU
and 5 of them were preterm neonates. Principal character-
istics of these patients and associated strains are given in
Table 2. Antimicrobial susceptibility was tested for the 12
MSSA strains from the 6 patients (Table 2). The 12 strains
were mostly penicillinase producers (n = 11) and suscep-
tible to most antibiotic classes except one strain resistant
to macrolides. Most strains lacked virulence factors since
only one carried tst, the gene encoding for toxic shock
syndrome toxin 1 and one other carried sea coding for
enterotoxin A. PFGE-typing for the 12 strains revealed a
predominant profile named pulsotype C and shared by
8 strains isolated from 4 patients (Table 2). Interestingly,
some isolates with the same pulsotype displayed different
content in virulence genes.
The synopsis of the IC team’s interventions and investi-
gations is presented in Table 3. During the environmental
investigation, a high level of surface contamination (109
surfaces sampled) in all areas (average rate of 82.6%) ofns by care sector in 2009.
Figure 3 MSSA and MRSA monthly prevalence in 2009 for NCC.
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such as Enterococcus faecalis, Pseudomonas aeruginosa
and MSSA. MSSA were isolated from a rack of electric
syringes, medical records of patient, 2 spare beds stored in
the hallway, and an incubator. All of these environmental
MSSA strains were typed by PFGE and differed from the
profile C. Water samples (n = 19) at various points of use
were also analyzed, but none was positive for SA.
The clinical audit of hand hygiene practices revealed
compliance rates of 60% in the NICU (14 persons assessed)
and 76% in the PRICU (16 persons assessed). Non-
compliance with recommendations was mostly due to
the concatenation of multiple care sequences for the
same patient, for example the absence of hand hygiene
between a contaminated care (nap change) and a clean
one (catheter manipulation). The assessment of central
venous catheter manipulations in the PRICU revealed
failures in catheter monitoring: catheter insertion points
were covered with opaque dressings preventing visual
control, and the frequency of dressing changes wasFigure 4 Evolution of SA infections in 2009 in NCC.insufficient. Furthermore, health-care workers always
wore white over-gowns whenever tending to a catheter or
coming into direct contact with perfused patients. These
gowns were stored in a drawer of the incubator until
re-use. During the observations, these white gowns were
pointed out as a potential bacterial reservoir or source of
cross-contamination. Thereby, 35 of them were sampled
in December: 25 gowns in the PRICU and 10 in the
NICU. Many of them were positive (15/35) for several
pathogens including SA, which was found on 8 separate
gowns. Overall these gowns showed a high level of con-
tamination (on average 50 CFU/25 cm2). SA strains were
not typed due to the delay since the summer outbreak but
the level of contamination suggested that misuse of these
gowns could promote the transmission of pathogens.
Discussion and conclusion
The study of SA epidemiology in the Montpellier NCC
showed an MSSA infection outbreak in the context of
SA endemicity. The overall prevalence of SA in 2009
was consistent with other published studies [11,21]. The
SA outbreak consisted mostly of bloodstream and respira-
tory tract infections, mainly caused by the same clone in
PFGE. Observations by the IC team suggested that slack
healthcare practices could be directly linked to the out-
break. Poor practice concerned mainly the manipulation
and monitoring of central venous catheters, and the use of
non-disposable white gowns. Aside from constant atten-
tion to hand hygiene [22,23], the complexity of care in
neonatology requires a perfect knowledge of infection
control principles, enabling healthcare professionals to
cluster interventions by risk level so as to limit self-
contamination of the patient or contamination of his
Table 2 Principal clinical characteristics of outbreak patients and strains
Patient Reason of admission Samples Nature of sample NCC sector PFGE profile MSSA/MRSA luk-PV sea tst Penicilline G Oxacilline Kanamycin
1 Prematurity and NEC 1A BSI NICU A MSSA S S S
1B PRICU B MSSA R S S
2 Severe epileptic encephalopathy 2A BSI PRICU C MSSA R S S
2B Conjunctivitis C MSSA + R S S
3 Prematurity and NEC 3A Insertion point of KT PRICU C MSSA R S S
3B KT C MSSA ND ND ND R S S
3C C MSSA ND ND ND R S S
4 Prematurity 4A BSI PRICU Untypable MSSA R S S
4B Untypable MSSA ND ND ND R S S
5 Prematurity 5A Tracheal Asp. PRICU C MSSA R S S
5B BL C MSSA + R S S



















Table 2 Principal clinical characteristics of outbreak patients and strains (Continued)
Patient Gentamicin Tobramycin Tetracycline Macrolides Cotrimoxazole Fluoroquinolones Rifamycin Fusic acid Fosfomycin Glycopeptides Linezolid
1 S S S S S S S S S S S
S S S S S S S S S S ND
2 S S S S S S S S S S S
S S S S S S S S S S S
3 S S S S S S S S S S ND
S S S S S S S S S S ND
S S S S S S S S S S ND
4 S S S S S S S S S S S
S S S S S S S S S S S
5 S S S S S S S S S S ND
S S S R S S S S S S S
6 S S S S S S S S S S S
NEC: necrotizing enterocolitis, BSI: bloodstream infection, KT: catheter, Asp.: aspiration, BL: bronchial liquid, luk-PV, gene coding for Panton-Valentine leukocidin; sea, genes coding for staphylococcal enterotoxins A; tst,



















Table 3 Outbreak investigation and IC interventions
Actions Dates
Case study August 07, 17 and 18, 2009
- Clinical records review and
strains typing
Environmental investigation August 05, 12, September 15
and October 13, 2009
- Surface and water sampling
- Gowns December 2009 (retrospectively)
Hygiene practices assessment October 01, 2009
- Hand hygiene October 19, 24 and
November 09, 2009
- Catheter-linked practices
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progressive contamination of hands or gloves [24] and
identified key opportunities for hand hygiene during
routine cares, even if wearing gloves, because of possible
hand contamination during removal [22]. Moreover, health
care workers’ white coats remain a controversial subject,
supposedly protecting the patient during central venous
catheter manipulations, but highly contaminated by patho-
gens for most of them (about a quarter positive for SA). As
previously described by Treakle et al. in 2009, we could
imagine that they were a vector of patient-to-patient
transmission, relaying SA circulation and outbreak in the
NCC [25]. However, we did not investigate the possibility
of SA chronic carriage by a health care worker which
could also have relayed the outbreak [8,26].
The typological analysis of colonized sites and infections
occurring in 2009 showed a majority of cases in the
PRICU, where patients are most susceptible to infections.
The occurrence of catheter-related infections in the sum-
mer was consistent with the increased SA prevalence
(colonization pressure), and slack catheter monitoring.
Catheter-related infections are the most common health-
care associated infections in NICUs [22,27,28]. The gen-
eral strategy for their prevention is based on good practice
recommendations concerning (i) insertion and mainten-
ance of indwelling lines, (ii) administration of prophylactic
antibiotics e.g.: antibiotic lock therapy, (iii) use of skin
emollients to reduce bacterial penetration, and (iv) health-
care workers and visitors donning of single-use gowns
[22]. However in our NCC, points (ii) and (iii) were not
applied and compliance with points (i) and (iv) was not
optimal.
SA is a significant pathogen in neonatology and an im-
portant cause of morbidity [7]. Epidemiological studies of
MRSA in NICUs have reported widely varying prevalence
rates, ranging from 0.6 to 53% [6,7,21,29,30], and MRSA
outbreaks are often described [6,31]. Far less attention is
given to MSSA. In the Montpellier NCC, MRSA preva-
lence appeared rather low (1.53% in 2009, ranging from 0
to 6.1%), and quantitatively a less important problem thanMSSA. We believe the commonly encouraged focus on
MRSA surveillance [22,27,28] may lead to unrecognized
or underestimated spread of MSSA. This is particularly
worrying for infection control in wards where MSSA is
the most prevalent SA type, as we observed for the NCC.
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